logo

For the Inventor, By the Inventor

West Lafayette, IN, United States of America

Endocyte, Inc.

Calculating rank
USPTO Granted Patents = 60

% Expired Patents = 53.3



Trademarks = 2

Forward Citations = 797

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Christopher Paul Leamon (54 out of 57 patents)

silverMedal Iontcho Radoslavov Vlahov (39 out of 40 patents)

bronzeMedal Philip Stewart Low (16 out of 112 patents)

4.  Hari Krishna R Santhapuram (12 out of 12 patents)

5.  Paul Joseph Kleindl (9 out of 9 patents)

6.  Joseph Anand Reddy (8 out of 8 patents)

7.  Kevin Yu Wang (8 out of 8 patents)

8.  Fei You (7 out of 7 patents)

9.  Yingjuan June Lu (7 out of 9 patents)

10.  Matthew A Parker (7 out of 7 patents)

11.  Stephen J Howard (6 out of 43 patents)

12.  Apparao Satyam (6 out of 11 patents)

13.  Haiyan Chu (6 out of 7 patents)

14.  Marilynn Vetzel (4 out of 4 patents)

15.  Melissa Nelson (4 out of 4 patents)


Core Competencies:
CAR T Cells
PSMA Conjugates
Imaging Agents
Folate Receptor
Tumor Treatment
Drug Delivery
Conjugates
Vitamin Receptor
Multi-Drug Ligands
Tubulysins
Hydrophilic Spacer Linkers
Combination Therapies

60 patents:

1. 12473265 - Methods for preparing PSMA conjugates (2025-11-18),
2. 12269862 - Methods of use for CAR T cells (2025-04-08),
3. 12240870 - Sequencing method for CAR T cell therapy (2025-03-04),
4. 12208102 - Methods of treating cancer (2025-01-28),
5. 12178892 - Compounds for positron emission tomography (2024-12-31),
6. 12144850 - Methods and compositions for car T cell therapy (2024-11-19),
7. 11850262 - Compositions and methods for CAR T cell therapy (2023-12-26),
8. 11779602 - Methods of use for CAR T cells (2023-10-10),
9. 11759480 - Compositions and methods for CAR T cell therapy (2023-09-19),
10. 11219622 - Folate receptor binding conjugates of antifolates (2022-01-11),
11. 10912840 - Conjugates for treating diseases caused by PSMA expressing cells (2021-02-09),
12. 10898596 - Conjugates for imaging (2021-01-26),
13. 10857234 - Carbonic anhydrase IX inhibitor conjugates and uses thereof (2020-12-08),
14. 10738086 - Conjugates containing hydrophilic spacer linkers (2020-08-11),
15. 10647676 - Bivalent linkers and conjugates thereof (2020-05-12),
Company Overview
Endocyte, Inc., based in West Lafayette, Indiana, specializes in innovative cancer therapies, focusing on targeted drug delivery systems. The company is known for its development of CAR T cell therapies and PSMA conjugates, which aim to enhance the precision of tumor treatment. Additionally, Endocyte is engaged in creating imaging agents and exploring the therapeutic potential of folate receptors and vitamin receptors, contributing to advancements in oncology and personalized medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Endocyte, Inc. USPTO Patent Assignee Logo
60 Patents

#5 in West Lafayette, IN

#103 in Indiana

#5,999 in US

#12,098 in the World

West Lafayette, IN (US)
West Lafayette, IN, United States of America

Endocyte, Inc.

Forward Citations = 797

50 inventors:

goldMedal Christopher Paul Leamon (54 out of 57 patents)

silverMedal Iontcho Radoslavov Vlahov (39 out of 40 patents)

bronzeMedal Philip Stewart Low (16 out of 112 patents)

4.  Hari Krishna R Santhapuram (12 out of 12 patents)

5.  Paul Joseph Kleindl (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Endocyte, Inc.. Retrieved from https://idiyas.com/company/endocyte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…